Yahoo Finance

FORT LAUDERDALE, FL / ACCESSWIRE / October 3, 2024 / ALUF Holdings, Inc. (OTC PINK:AHIX) Acting CEO and Director, Joseph Paresi, is pleased to announce that detailed planning and execution discussions have occurred with Aluf's new Chief Operating and Chief Technology Officer (COO/CTO), Dr. Matthew Leftwich, regarding the integration of existing contracts and new business opportunities, as the team moves toward accelerating the planned acquisition closing of Nanomatronix (NMX) before the end of 2024.

The near-term technology focus of Aluf and NMX has been on three key areas:

1. Microelectronics Screening and Qualification Testing - Continuation of the present NMX contracts for screening and qualification of optoelectronics subsystems in support of the USG plan to upgrade US satellites and other defense platforms. Screening begins in 2024 on two (2) multi-phase contracts with major DOD primes. Additional contract mechanisms with Defense, Aerospace, and Satellite providers have been identified and plans to pursue them have been established.

2. Biological Technologies - NMX has existing contracts with several pending and scheduled to begin within six months. These involve unique advancements in Biological Technologies (aka: Biotech) focused in two main areas - Advanced Organ-on-Chip (OOC) solutions and Wound Healing Technologies in collaboration with certain faculty of the University of Arkansas based on the unique inventions of (6) six key UA researchers.

   • Organ-on-chip (OOC) technologies involve microfluidic cell culture chips that mimic the functions, mechanics, and physiological responses of an organ, or organ system. The key discriminator differentiating NMX technologies from competitive approaches is the ability to measure Trans-epithelial/Trans-endothelial Electrical Resistance (TEER), a major discriminator in analyzing drug effects on live tissue. Other optical sensing mechanisms are being added for additional flow study capability that further differentiates NMX tech over their primary competitor in this space.

   • NMX is targeting three initial areas of OOC product releases: Advanced Micro-physiological Brain Injury Technology (AMBIT), for TBI studies and drug/treatment development; Nasal Airway Chips (NAC), to perform epidemiological studies of particle effects on the respiratory system and drug/treatment development; and Heart Valve Organ Chips (HaVOC), to study and develop treatments for diseases and conditions associated with Heart Valve issues.

   • Wound Healing efforts are focused on three initial enabling technologies: Gold Nano-constructs for Infection Remediation (AuNIR), aimed at combating drug-resistant infections; Injectable matrix Gels (InMaG), initially aimed at repairing degenerated rotator cuff muscles; and Fibroblast Injectable Anionic Hydrogels (FLIAH/shFGF1), aimed at healing diabetic induced skin wounds.

3. Carbon Nanotube Technology (CNT) - Dr. Leftwich has developed a unique approach to manufacturing ultra-long Carbon Nanotubes (UL-CNTs) as an advanced technology for the next generation of high strength-to-weight ratio materials and advanced x-ray sources. Specifically, longer length carbon nanotubes are expected to be an upgrade to a broad range of carbon fiber solutions. Further, NMX has developed a process to manufacture CNT material in lengths over twenty times (20x) longer than existing approaches, enabling CNT-based applications not yet realized. CNT-based composites have tensile strength over 10 times greater than existing carbon fiber composites and reveal significant improvements in strength-to-weight ratio that could allow for significant improvements in aircraft, structural, and multi-functional materials. R&D is ramping-up to extend pure CNT lengths beyond 1 cm (post-harvest) for direct integration into novel CNT-composites.

   • The numerous advantages of this material will apply to advancement in defense and aerospace applications including aircraft, drones, missiles, armored vehicles, commercial vehicles, and bullet-proof materials, amongst others, as well as a solid-state solution to replace costly and less reliable x-ray technologies as used in medical, security and manufacturing, including non-destructive testing.